Important Dates
Early Bird Registration :20th December 2026
Paper Submission Deadline :25th December 2026
Last Date of Registration : 4th January 2027
Date of Conference : 19th - 20th January 2027
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Track 01
Pathophysiology of Diabetic Neuropathy
This session will explore the underlying mechanisms of diabetic neuropathy, focusing on the biochemical and physiological changes that contribute to nerve damage. Emphasis will be placed on recent findings that enhance our understanding of disease progression.
Track 02
Pharmacological Interventions in Pain Management
This track will discuss the latest advancements in pharmacological treatments for managing diabetic neuropathy pain. Participants will review clinical trial outcomes and the efficacy of various drug classes in alleviating symptoms.
Track 03
Lifestyle Interventions and Patient Outcomes
This session will highlight the role of lifestyle modifications in the management of diabetic neuropathy. Evidence-based strategies aimed at improving patient quality of life through diet, exercise, and behavioral changes will be examined.
Track 04
Early Detection and Biomarkers of Diabetic Neuropathy
This track will focus on the identification of biomarkers that facilitate the early detection of diabetic neuropathy. Discussions will include innovative diagnostic tools and their potential impact on clinical practice.
Track 05
Nerve Damage Mechanisms in Diabetes
This session will delve into the specific mechanisms of nerve damage associated with diabetes. Insights into the role of oxidative stress, inflammation, and metabolic dysregulation will be presented.
Track 06
Integrative Approaches to Pain Management
This track will explore integrative approaches combining pharmacological and non-pharmacological methods for effective pain management in diabetic neuropathy. Case studies and clinical experiences will be shared to illustrate best practices.
Track 07
Quality of Life Assessments in Diabetic Patients
This session will address the importance of quality of life assessments in patients with diabetic neuropathy. Participants will learn about various tools and methodologies used to evaluate patient-reported outcomes.
Track 08
Innovations in Clinical Practice for Diabetic Neuropathy
This track will showcase innovative clinical practices and treatment protocols for managing diabetic neuropathy. Attendees will gain insights into the implementation of new technologies and methodologies in patient care.
Track 09
Psychosocial Aspects of Diabetic Neuropathy
This session will examine the psychosocial impact of diabetic neuropathy on patients and their families. Discussions will focus on coping strategies, mental health considerations, and support systems.
Track 10
Current Trends in Research on Diabetic Neuropathy
This track will provide an overview of the latest research trends in diabetic neuropathy. Participants will engage with emerging studies that could shape future therapeutic approaches.
Track 11
Patient-Centered Care in Diabetic Neuropathy
This session will emphasize the importance of patient-centered care in the management of diabetic neuropathy. Strategies for enhancing patient engagement and shared decision-making will be discussed.